XML 40 R30.htm IDEA: XBRL DOCUMENT
v3.23.3

Other Income / (Expense) (Tables) | 3 Months Ended
--- | ---
Sep. 30, 2023
Notes Tables |
Schedule of the components of other income (expense) | The components of other income (expense) in the accompanying Statement of Earnings and Comprehensive Income are as follows (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Quarter Ended
​ | ​ | September 30,
​ |  | 2023 |  | 2022
Interest expense | ​ | $ | (4,893) | ​ | $ | (3,790)
Interest income | ​ | ​ | 890 | ​ | ​ | 433
Gain (loss) on investment(1) | ​ | ​ | 283 | ​ | ​ | 49,769
Gain (loss) on equity method investment | ​ | ​ | (2,290) | ​ | ​ | —
Other non-operating income (expense), net | ​ |  | (294) | ​ |  | 987
Total other income (expense) | ​ | $ | (6,304) | ​ | $ | 47,399
​
| (1) | Primarily due to a $0.3 million gain on the sale of our exchange traded investment grade bond funds during the quarter ended September 30, 2023 compared to a $37.2 million gain on the sale of our ChemoCentryx investment and a $11.7 million gain on the sale of Eminence in the quarter ended September 30, 2022.

X
- Definition Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items. + References No definition available. + Details
Name: | us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_TableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration